Clinical Trials Directory

Trials / Unknown

UnknownNCT02975284

Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study

TASMA Extension Study: Long Term Efficacy and Safety of Bronchial Thermoplasty in Severe

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the longterm clinical outcomes, including safety and efficacy parameters after Bronchial Thermoplasty (BT) treatment over a period of 5 years. All patients included in de TASMA trial in the Netherlands will be asked to participate in the TASMA extension study.

Conditions

Timeline

Start date
2015-08-01
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2016-11-29
Last updated
2019-07-05

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02975284. Inclusion in this directory is not an endorsement.

Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study (NCT02975284) · Clinical Trials Directory